Ticker Scorecard - HROW Basics Company: Harrow Health, Inc. Common Stock IPO Date: October 1, 2007 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $1.2B Activated in VL: True Average Daily Range Avg Daily Range: $0.42 | 2.72% Avg Daily Range (30 D): $0.90 | 2.47% Avg Daily Range (90 D): $1.16 | 2.67% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .27M Avg Daily Volume (90 D): .39M Trade Size Avg Trade Size (Sh.): 74 Avg Trade Size (Sh.) (30 D): 41 Avg Trade Size (Sh.) (90 D): 47 Institutional Trades Total Inst.Trades: 439 Avg Inst. Trade: $1.87M Avg Inst. Trade (30 D): $1.73M Avg Inst. Trade (90 D): $2.04M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.09M Avg Closing Trade (30 D): $1.77M Avg Closing Trade (90 D): $2.33M Avg Closing Volume: 92.26K     News Jul 19, 2024 @ 5:31 AM Nicox announces attendance at upcoming conferences... Source: N/A Jul 16, 2024 @ 5:31 AM Nicox appoints experienced biotech leader Damian M... Source: Nicox Jun 21, 2024 @ 6:44 AM Harrow (HROW) Soars 12.9%: Is Further Upside Left ... Source: Zacks Equity Research May 9, 2024 @ 1:15 PM VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Mis... Source: Zacks Equity Research Mar 25, 2024 @ 1:00 PM Insiders Buying Greenwich LifeSciences And 2 Other... Source: Avi Kapoor Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.12 $-.18 $-.38 Diluted EPS $-.12 $-.18 $-.38 Revenue $ 49.26M $ 48.94M $ 34.59M Gross Profit $ 37.24M $ 36.4M $ 24.03M Net Income / Loss $ -4.22M $ -6.47M $ -13.57M Operating Income / Loss $ 1.32M $ 1.53M $ -6.93M Cost of Revenue $ 12.02M $ 12.54M $ 10.55M Net Cash Flow $ 1.63M $ 2.43M $ -5.55M PE Ratio     Splits Feb 08, 2013:   5:1